Dermavant Sciences Ltd Business Finance Contracts & Agreements
10 Contracts & Agreements
- Exchange Agreements (1 contract)
- Funding Agreements (2)
- Loan Agreements (1)
- Purchase Agreements (3)
- Registration Rights Agreements (1)
- Underwriting Agreements (1)
- Warrant Agreements (1)
- Intercreditor Agreement, dated as of May 24, 2019, by and between Hercules Capital, Inc., the Intra-Group Lenders (as defined in the agreement), the Intra-Group Debtors (as... (Filed With SEC on June 10, 2019)
- Warrant Agreement, dated as of May 31, 2019, by and between Dermavant Sciences Ltd. and Hercules Capital, Inc (Filed With SEC on June 10, 2019)
- Loan and Security Agreement, dated as of May 24, 2019, by and between Dermavant Sciences Ltd., Dermavant Sciences, Inc., Dermavant Sciences GmbH and Dermavant Holdings Limited and... (Filed With SEC on June 10, 2019)
- Registration Rights Agreement, dated as of June 7, 2019, by and between Roivant Sciences Ltd. and the Registrant (Filed With SEC on June 10, 2019)
- Form of Underwriting Agreement (Filed With SEC on June 10, 2019)
- Asset Purchase Agreement, dated May 29, 2012, by and between Glaxo Group Limited and Welichem Biotech Inc., as amended (Filed With SEC on May 24, 2019)
- First Amendment, effective as of October 11, 2018, to the Funding Agreement, dated as of July 10, 2018, by and between Dermavant Sciences GmbH and NovaQuest Co-Investment Fund... (Filed With SEC on May 24, 2019)
- Funding Agreement, dated as of July 10, 2018, by and between Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P (Filed With SEC on May 24, 2019)
- China and South Korea IP Purchase Agreement, effective as of June 12, 2017, by and between Dermavant Sciences GmbH and Roivant Sciences GmbH (Filed With SEC on May 24, 2019)
- Asset Purchase Agreement, dated as of July 10, 2018, by and among Dermavant Sciences GmbH, GlaxoSmithKline Intellectual Property Development Ltd. and Glaxo Group Limited (Filed With SEC on May 24, 2019)
